| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0091-6749(00)90059-9 |
| P698 | PubMed publication ID | 10669540 |
| P2093 | author name string | Geha RS | |
| Bacharier LB | |||
| P2860 | cites work | Involvement of CRAF1, a relative of TRAF, in CD40 signaling | Q24306746 |
| Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains | Q24310724 | ||
| The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor | Q24311786 | ||
| The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics | Q24561800 | ||
| Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function | Q24563054 | ||
| Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein | Q24599252 | ||
| TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling | Q24634187 | ||
| Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2 | Q24680231 | ||
| A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor | Q28236769 | ||
| Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells | Q28244421 | ||
| Recombinant interferon gamma therapy for atopic dermatitis | Q28266125 | ||
| Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene | Q28276209 | ||
| Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain | Q28281946 | ||
| TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor | Q28282051 | ||
| The CD40 antigen and its ligand | Q28286277 | ||
| NF-AT-Driven interleukin-4 transcription potentiated by NIP45 | Q28298319 | ||
| The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
| Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region | Q28511583 | ||
| The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation | Q28586300 | ||
| RAG-1-deficient mice have no mature B and T lymphocytes | Q28592133 | ||
| RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement | Q28594711 | ||
| Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons | Q28609580 | ||
| TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
| Functional diversity of helper T lymphocytes | Q29619415 | ||
| Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to immunoglobulin (Ig) G1 and IgE | Q30435016 | ||
| CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells | Q30442717 | ||
| CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated p | Q30442865 | ||
| Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM | Q30454072 | ||
| Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor | Q33633115 | ||
| Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome | Q34251749 | ||
| IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma | Q34292243 | ||
| Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. | Q34320792 | ||
| CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. | Q35962812 | ||
| Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. | Q36107871 | ||
| Homodimerization of the human interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in B cells in the absence of the interleukin 2 receptor gamma chain | Q36160292 | ||
| Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen | Q36230750 | ||
| Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. | Q36261169 | ||
| Induction of human IgE synthesis by CD4+ T cell clones. Requirement for interleukin 4 and low molecular weight B cell growth factor | Q36356982 | ||
| Disodium cromoglycate inhibits S mu-->S epsilon deletional switch recombination and IgE synthesis in human B cells | Q36363488 | ||
| Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: regulation by NF-IL-4, a C/EBP family member and NF-kappa B/p50. | Q36364256 | ||
| Molecular characterization and functional analysis of murine interleukin 4 receptor allotypes | Q36380842 | ||
| Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation | Q36564433 | ||
| The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. | Q36804149 | ||
| IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain | Q37358006 | ||
| Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. | Q37412303 | ||
| Deletional switch recombination occurs in interleukin-4-induced isotype switching to IgE expression by human B cells. | Q37583595 | ||
| Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction | Q38317997 | ||
| Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody | Q39250528 | ||
| What to do at an end: DNA double-strand-break repair | Q40372175 | ||
| Cytokine receptor signalling | Q40416594 | ||
| Cytokines and STATs: how can signals achieve specificity? | Q40451329 | ||
| Jumping genes and the immunoglobulin V gene system | Q40542269 | ||
| Signals and signs for lymphocyte responses | Q40620206 | ||
| How B and T cells talk to each other | Q40714365 | ||
| Towards a comprehensive view of immunoglobulin class switching | Q40880908 | ||
| Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes | Q41020266 | ||
| A central role of CD40 ligand in the regulation of CD4+ T-cell responses | Q41149910 | ||
| RAG mutations in human B cell-negative SCID. | Q41159572 | ||
| The immunoglobulin class switch: beyond "accessibility". | Q41389958 | ||
| CD40 ligation induces lymphotoxin alpha gene expression in human B cells | Q41425894 | ||
| IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells | Q41527015 | ||
| Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production | Q41727465 | ||
| An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors | Q41917400 | ||
| Interleukin 13 is a B cell stimulating factor | Q42075980 | ||
| Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens | Q42155789 | ||
| Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients | Q42625831 | ||
| Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin | Q42683940 | ||
| Antibody class switch recombinase activity is B cell stage specific and functions stochastically in the absence of 'targeted accessibility' control | Q42799108 | ||
| Endogenous interleukin 6 plays an obligatory role in interleukin 4-dependent human IgE synthesis | Q43890178 | ||
| Components of a Stat recognition code: evidence for two layers of molecular selectivity | Q44747920 | ||
| The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor | Q46855643 | ||
| The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms | Q48284399 | ||
| The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. | Q52199701 | ||
| Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. | Q52522634 | ||
| IFN-gamma represses epsilon germline transcription and subsequently down-regulates switch recombination to epsilon. | Q54253225 | ||
| CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome | Q55670500 | ||
| Generation and analysis of interleukin-4 deficient mice | Q57339987 | ||
| Role of protein tyrosine kinases and phosphatases in isotype switching: crosslinking CD45 to CD40 inhibits IgE isotype switching in human B cells | Q57464570 | ||
| Role of protein tyrosine kinases in CD40/interleukin-4-mediated isotype switching to IgE | Q57464577 | ||
| CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM | Q58478788 | ||
| Inhibition of the Prausnitz–Küstner reaction by an immunoglobulin ε-chain fragment synthesized in E. coli | Q59084329 | ||
| Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM | Q59086599 | ||
| Interleukin-4 receptor expression by human B cells: functional analysis with a human interleukin-4 toxin, DAB389IL-4. | Q64994269 | ||
| Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels | Q67285108 | ||
| A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes | Q67899863 | ||
| Mechanisms of inhibition of IgE synthesis by nedocromil sodium: nedocromil sodium inhibits deletional switch recombination in human B cells | Q71071177 | ||
| Repair and Recombination: How to make ends meet | Q71798135 | ||
| The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome | Q72068543 | ||
| Mice deficient for the CD40 ligand | Q72610555 | ||
| Interleukin 4 receptor: signaling mechanisms | Q72768332 | ||
| Systemic interferon gamma treatment in severe atopic dermatitis | Q72789565 | ||
| X-SCID B cell responses to interleukin-4 and interleukin-13 are mediated by a receptor complex that includes the interleukin-4 receptor alpha chain (p140) but not the gamma c chain | Q73043240 | ||
| Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells | Q73144454 | ||
| Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells | Q73302828 | ||
| P433 | issue | 2 Pt 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | S547-58 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Molecular mechanisms of IgE regulation | |
| P478 | volume | 105 |
| Q37144283 | A protective role for the fifth complement component (c5) in allergic airway disease |
| Q36916340 | Activating transcription factor 3 is a negative regulator of allergic pulmonary inflammation |
| Q37878272 | Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis |
| Q33691367 | An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation. |
| Q26865224 | Are basophils important mediators for helminth-induced Th2 immune responses? A debate |
| Q53646208 | Aspartame Attenuates 2, 4-Dinitrofluorobenzene-Induced Atopic Dermatitis-Like Clinical Symptoms in NC/Nga Mice. |
| Q31108758 | Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults |
| Q21092301 | Association of the gene polymorphisms IFN-gamma +874, IL-13 -1055 and IL-4 -590 with patterns of reinfection with Schistosoma mansoni |
| Q50057530 | Atopic dermatitis physiopathology |
| Q47816883 | Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. |
| Q42723837 | Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac Dysfunction |
| Q34007793 | Bone marrow-derived clonal mesenchymal stem cells inhibit ovalbumin-induced atopic dermatitis |
| Q79951348 | CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli |
| Q46760246 | CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli. |
| Q37307447 | Cathelicidin deficiency predisposes to eczema herpeticum |
| Q35209859 | Clinical value and measurement of specific IgE. |
| Q47937079 | Decorating and loading ghosts with allergens for allergen immunotherapy. |
| Q43181485 | Detection of true IgE-expressing mouse B lineage cells |
| Q81609274 | Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells |
| Q47912150 | Effects of low concentrations of cadmium on immunoglobulin E production by human B lymphocytes in vitro |
| Q99415094 | Establishment of a novel nomogram for the clinically diagnostic prediction of minimal change disease, -a common cause of nephrotic syndrome |
| Q46898490 | Fatty acid composition of serum lipid classes in mice following allergic sensitisation with or without dietary docosahexaenoic acid-enriched fish oil substitution |
| Q34516824 | Food allergy. Mechanisms, diagnosis, and management in children. |
| Q54002929 | Genetic control of resistance to mercury-induced immune/autoimmune activation. |
| Q35096984 | Haemophilus influenzae and smoking-related obstructive airways disease |
| Q33956641 | Idiopathic nephrotic syndrome and atopy: is there a common link? |
| Q35627706 | Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombination. |
| Q59811155 | Immunoglobulin E and G Levels in Predicting Minimal Change Disease before Renal Biopsy |
| Q38883893 | Immunologic Targets in Atopic Dermatitis and Emerging Therapies: An Update |
| Q35908303 | Immunopathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis |
| Q38585600 | Immunopathology and immunogenetics of allergic bronchopulmonary aspergillosis |
| Q43707115 | Increased serum IgE in alcoholics: relationship with Th1/Th2 cytokine production by stimulated blood mononuclear cells |
| Q43872895 | Influence of alcohol consumption on serum immunoglobulin E levels in atopic and nonatopic adults |
| Q51721377 | Inhalation of a harmless antigen (ovalbumin) elicits immune activation but divergent immunoglobulin and cytokine activities in mice. |
| Q49804257 | Inhibitory Activity of Allergic Contact Dermatitis and Atopic Dermatitis-Like Skin in BALB/c Mouse through Oral Administration of Fermented Barks of Alnus sibirica |
| Q54561900 | Interleukin-16 inhibits immunoglobulin e production by B lymphocytes. |
| Q33725722 | Intestinal microbial diversity during early-life colonization shapes long-term IgE levels |
| Q48360802 | Low immunoglobulin E flags two distinct types of immune dysregulation |
| Q28265740 | Management of allergic bronchopulmonary aspergillosis: a review and update |
| Q45863392 | Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis |
| Q35618367 | Neurotrophins and neurotrophin receptors in allergic asthma |
| Q34134867 | New trends in immunotherapy to prevent atopic diseases |
| Q50949440 | Oral administration of pulverized Konjac glucomannan prevents the increase of plasma immunoglobulin E and immunoglobulin G levels induced by the injection of syngeneic keratinocyte extracts in BALB/c mice. |
| Q36740480 | Parent psychological states predict changes in inflammatory markers in children with asthma and healthy children |
| Q23924178 | Pathogenesis and disease mechanisms of occupational asthma |
| Q40561124 | Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survival. |
| Q37857666 | Pimecrolimus cream in the management of patients with atopic eczema |
| Q62801972 | Reduction in polyamine catabolism leads to spermine-mediated airway epithelial injury and induces asthma features |
| Q38541195 | Regulation of IgE Responses by γδ T Cells |
| Q34567533 | Regulation of allergic airways inflammation by cytokines and glucocorticoids |
| Q36187412 | Reprogramming IgH isotype-switched B cells to functional-grade induced pluripotent stem cells |
| Q50189250 | Role of IL-13 Genetic Variants in Signalling of Asthma |
| Q36000599 | STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects. |
| Q41822492 | Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing |
| Q41571840 | Serum free IgE guided dose reduction of omalizumab: a case report |
| Q36999549 | Single nucleotide polymorphism in the promoter of the human interleukin-13 gene is associated with asthma in Malaysian adults |
| Q34650356 | Sputum IgE and cytokines in asthma: relationship with sputum cellular profile |
| Q44586207 | T-bet as a possible therapeutic target in autoimmune disease |
| Q28588979 | T-bet regulates IgG class switching and pathogenic autoantibody production |
| Q37102389 | Th17 cell-derived IL-17 is dispensable for B cell antibody production |
| Q41948431 | The Other T Helper Cells in Asthma Pathogenesis |
| Q91939726 | The Role of Interleukin-4 and 13 Gene Polymorphisms in Allergic Rhinitis: A Case Control Study |
| Q36053485 | The clinical characteristics of steroid responsive nephrotic syndrome of children according to the serum immunoglobulin E levels and cytokines |
| Q36159337 | The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders |
| Q35774952 | Toll-like receptors and immune response in allergic disease |
| Q34932177 | Toll-like receptors as potential therapeutic targets for multiple diseases |
| Q98726310 | Total Serum Immunoglobulin E Levels in Patients with Psoriasis |
| Q39804763 | Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. |
| Q38134468 | Update on allergen immunotherapy for treatment of allergic diseases |
Search more.